国家卫健委：4月5日新增新冠肺炎确诊病例1415例 其中本土病例1383例

由

Vivus

公司开发的

Qsymia

作为十多年内首次被美国

FDA

批准的减肥药销售状况并不乐观,为此

Vivus

除了增加常规渠道的销售力量,还推出了协助减肥的手机

app

。

据路透社报导,研究人员发现当超重或者肥胖人员收到手机

app

的监督时,可以实现正常减肥项目以外的额外

8

磅的减肥效果。所以

Vivus

公司正要求旗下的

150

名销售人员向

2

万

5

千名医生推销

Qsymia

的同时,也介绍这款新的

app

希望此举能够促进药物的销售。具体来说,这款手机

app

能让使用者记录每天的饮食,并收到定期的关于减肥的指导。

英文报道：

Vivushopesweight-lossappwillfattenupQsymiasales

Weight-lossappshavebecomepopular,sowhynotaweight-lossappforaweight-lossdrug?QsymiamakerVivusfiguresitisworthatry.

Thecompany($VVUS),whichhasfoundtheuptakeslowonitshighlyvaunteddrug,lastweeklaunchedamobileversionoftheweight-losssupporttoolsalreadyonitswebsite,MedicalMarketing&Mediareports.Theapp,whichworksonAndroidandAppleproducts,hasadiary,souserscannoteeverythingtheyeatandgetinformationalemailsrolledoutperiodicallytogivethemideasonhowtoloseweightoverayear'stime.

RobJanosky,seniordirector,commercialdevelopmentatVivus,toldMM&Mthatits150salesrepsareexplainingthetechnologytothe25,000U.S.doctorsthattheytarget.Hesaidseveralthousandusershadsignedupforthedigitaltools,explaining,"There'snomagicbulletforweightloss."

Arecentstudysuggestedthatusingappsforweightlosscanhelp,though.AccordingtoReuters,researchersfoundthatoverweightandobeseadultslostanaverageofmorethan8poundswhentheygotcoachingfromamobiledeviceinadditiontoagroupweight-lossprogram."Thenumberonemechanismthroughwhichpeopleloseweightisself-monitoring,justwatchingwhatyoueatandkeepingarecordofit,"Dr.GouthamRao,oneoftheresearchers,toldthenewsservice."I'mactuallyveryoptimisticthatpeoplewhoaremotivated,whocancouplethetechnologywithin-personcounselingandmanagementaregoingtobeverysuccessful."

Vivus'managementisgettingsomeheattobesuccessfulthemselves.Theyhavebeencriticizedbyinvestorswhothinktherolloutandsaleshavebeenlacklusterforthefirstweight-lossdrugapprovedbytheFDAinmorethan10years.Companyexecshavesaidtheyaretakingtimetogetbuy-infromdoctorsandpatients.Vivushasattemptedafreetrialoftheproduct,butJefferiesanalystThomasWeicalledthat"anonstarter,"MM&Mpointsout.

Someanalystshavebeenadamantthatwhatthecompanyreallyneedsisapartnerwiththemarketingmuscletopushthedrugharder.Initslastearningsreport,Vivusreportedawideningfourth-quarterlossof$56.7million,whichitpeggedtohighermarketingcosts.